EGFR and adenocarcinoma: If further research finds it to be similar to the EGFR gene mutation found in adenocarcinoma among high-risk groups, oncologists should consider testing female and non/mild smoking SQCLC patients for EGFR gene mutation status and begin TKIs treatment if appropriate.